Navigation Links
Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
Date:1/17/2008

LAKE FOREST, Ill., Jan. 17 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global hospital products company, today announced that it will host a conference call to discuss its fourth-quarter and full-year 2007 results and projections for 2008 on Thursday, Feb. 28, 2008, at 8 a.m. Central Time.

The company will release its fourth-quarter and full-year 2007 results earlier that morning, before the U.S. stock market open and the conference call.

A live webcast of the conference call will be available on Hospira's Web site at http://www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available on the Hospira Web site for 30 days following the call.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest offerings of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
2. Hospira Reports Third-Quarter 2007 Results
3. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
4. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
5. American Association for Cancer Research hosts 2008 annual meeting
6. Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2007 Earnings
7. The Pennsylvania Breast Cancer Coalition Hosts Seminar on Free Breast Cancer Treatment Program
8. AMWA Hosts Health Care Conversation With Congressman Kucinich
9. AARP Pennsylvania Hosts Panel on Strengthening Medicare
10. University of Pennsylvania study reveals inconspicuous hosts in the Lyme disease epidemic
11. National Council on Disability (NCD) Hosts Quarterly Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... December 05, 2016 , ... ... that the company will provide alerting technology to Central Illinois Health Information ... $1.7 million in federal funds as the sole sub-recipient participating with the ...
(Date:12/5/2016)... , ... December 05, 2016 , ... Dr. Barry M. ... Cosmetic Plastic Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium ... the newest techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is ...
(Date:12/5/2016)... ... December 05, 2016 , ... Florida Hospital has named Robin ... Region. McGuinness brings experience in executive leadership and clinical practice, as well as ... In her new role, that officially begins December 12, 2016, she will set ...
(Date:12/5/2016)... Franklin Lakes, NJ (PRWEB) , ... December 05, ... ... the recording studio teaming up on new songs with prolific Songwriter-Producer Corey “Chorus” ... Jamie Foxx, Kelly Rowland, Ciara, Brandy…just to name a few.     https://twitter.com/coreychorus ...
(Date:12/5/2016)... ... December 05, 2016 , ... The new knee compression sleeves come ... buy neoprene knee sleeves for lifting and any sport that requires knee ... two main aspects to provide a higher quality knee sleeve performance. Firstly it is ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)...  Wellbridge Health and Gateway Health proudly announce a dynamic ... and Medicaid plan members with specific high risk needs. ... of this group of consumers, Wellbridge combines technology and population ... insight into members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 ... today announced preliminary safety and efficacy data from ... oral selective MDM2 inhibitor, suggesting that DS-3032 may ... relapsed/refractory acute myeloid leukemia (AML) and high-risk myelodysplastic ... part of the phase 1 study of DS-3032 were ...
(Date:12/5/2016)... 2016 Eisai Inc. announced today new analyses ... Meeting of the American Epilepsy Society (AES). ... an adjunctive therapy for the treatment of partial onset ... primary generalized tonic-clonic seizures (PGTC) in patients with epilepsy ... see Important Safety Information for FYCOMPA, including Boxed WARNING ...
Breaking Medicine Technology: